Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Springer

Series Info

Metabolic Brain Disease;Volume 36, pages 1331–1340, (2021)

Orcid

Abstract

Hepatic encephalopathy (HE) is a debilitating and life-threatening disease. Results from acute or chronic liver failure and is characterized by abnormal cerebral and neurological alterations. This study aimed at investigating the effect of allicin, the major functional component in freshly crushed garlic extract, on thioacetamide (TAA)-induced HE in rats. Induction of HE by a single dose of TAA (300 mg/kg; I.P.) was associated with a marked elevation in the serum levels of alanine aminotransferase, aspartate aminotransferase, bilirubin, albumin, total protein, blood urea nitrogen and serum ammonia besides reduction in the serum level of albumin. Moreover, it was accompanied with an increase in the hepatic and brain levels of inflammatory mediators; TNF-α and IL-1β as well as elevation of the hepatic and brain levels of oxidative stress biomarkers; reduced glutathione and lipid peroxidation evidenced by malondialdeyde. Oral administration of allicin (50, 100 and 200 mg/kg; P.O.) for 6 days prior to TAA injection restored the serum liver function, hepatic and brain levels of inflammatory mediators as well as oxidative stress biomarkers in a dose-dependent manner. From our results, it can be concluded that allicin has a protective effect on TAA-induced HE in rats in a dose-dependent manner due to its powerful antioxidant and anti-inflammatory properties.

Description

SJR 2024 0.941 Q2 H-Index 83

Citation

Saleh, D. O., Mansour, D. F., & Fayez, A. M. (2021). Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin. Metabolic Brain Disease, 36(6), 1331–1340. https://doi.org/10.1007/s11011-021-00695-7 ‌

Endorsement

Review

Supplemented By

Referenced By